231 related articles for article (PubMed ID: 26240829)
1. Integrative Analysis with Monte Carlo Cross-Validation Reveals miRNAs Regulating Pathways Cross-Talk in Aggressive Breast Cancer.
Colaprico A; Cava C; Bertoli G; Bontempi G; Castiglioni I
Biomed Res Int; 2015; 2015():831314. PubMed ID: 26240829
[TBL] [Abstract][Full Text] [Related]
2. Monte Carlo cross-validation analysis screens pathway cross-talk associated with Parkinson's disease.
Li T; Tang W; Zhang L
Neurol Sci; 2016 Aug; 37(8):1327-33. PubMed ID: 27146810
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
4. Predicting pathway cross-talks in ankylosing spondylitis through investigating the interactions among pathways.
Gu X; Liu CJ; Wei JJ
Braz J Med Biol Res; 2017 Nov; 51(1):e6698. PubMed ID: 29160414
[TBL] [Abstract][Full Text] [Related]
5. Identification of differently expressed genes with specific SNP Loci for breast cancer by the integration of SNP and gene expression profiling analyses.
Yuan P; Liu D; Deng M; Liu J; Wang J; Zhang L; Liu Q; Zhang T; Chen Y; Jin G
Pathol Oncol Res; 2015 Apr; 21(2):469-75. PubMed ID: 25408372
[TBL] [Abstract][Full Text] [Related]
6. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
[TBL] [Abstract][Full Text] [Related]
7. Identification of significant pathway cross-talk in rheumatoid arthritis by the Monte Carlo cross-validation method.
Song W; Zhang YM; Ma T; Wang J; Wang KZ
Genet Mol Res; 2017 Apr; 16(2):. PubMed ID: 28387872
[TBL] [Abstract][Full Text] [Related]
8. Integrating differential pathway analysis with Monte Carlo cross-validation reveals seed cross-talks in non-small cell lung carcinoma.
Zheng ML; Zhou NK; Luo CH
J BUON; 2016; 21(5):1203-1209. PubMed ID: 27837624
[TBL] [Abstract][Full Text] [Related]
9. Sense-antisense gene-pairs in breast cancer and associated pathological pathways.
Grinchuk OV; Motakis E; Yenamandra SP; Ow GS; Jenjaroenpun P; Tang Z; Yarmishyn AA; Ivshina AV; Kuznetsov VA
Oncotarget; 2015 Dec; 6(39):42197-221. PubMed ID: 26517092
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics analysis of aggressive behavior of breast cancer via an integrated gene regulatory network.
Yang X; Jia M; Li Z; Lu S; Qi X; Zhao B; Wang X; Rong Y; Shi J; Zhang Z; Xu W; Gao Y; Zhang S; Yu G
J Cancer Res Ther; 2014; 10(4):1013-8. PubMed ID: 25579546
[TBL] [Abstract][Full Text] [Related]
11. Application of Monte Carlo cross-validation to identify pathway cross-talk in neonatal sepsis.
Zhang Y; Liu C; Wang J; Li X
Exp Biol Med (Maywood); 2018 Mar; 243(5):444-450. PubMed ID: 29513099
[TBL] [Abstract][Full Text] [Related]
12. Integrated analysis of miRNA, gene, and pathway regulatory networks in hepatic cancer stem cells.
Ding M; Li J; Yu Y; Liu H; Yan Z; Wang J; Qian Q
J Transl Med; 2015 Aug; 13():259. PubMed ID: 26259570
[TBL] [Abstract][Full Text] [Related]
13. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
[TBL] [Abstract][Full Text] [Related]
14. Screening biomarkers of bladder cancer using combined miRNA and mRNA microarray analysis.
Jin N; Jin X; Gu X; Na W; Zhang M; Zhao R
Mol Med Rep; 2015 Aug; 12(2):3170-6. PubMed ID: 25955758
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs dysregulated in breast cancer preferentially target key oncogenic pathways.
Lim WK; Micklem G
Mol Biosyst; 2011 Sep; 7(9):2571-6. PubMed ID: 21766137
[TBL] [Abstract][Full Text] [Related]
16. MiRNA expression analysis of cancer-associated fibroblasts and normal fibroblasts in breast cancer.
Zhao L; Sun Y; Hou Y; Peng Q; Wang L; Luo H; Tang X; Zeng Z; Liu M
Int J Biochem Cell Biol; 2012 Nov; 44(11):2051-9. PubMed ID: 22964023
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a transcriptional signature of breast cancer.
Feng Y; Li X; Sun B; Wang Y; Zhang L; Pan X; Chen X; Wang X; Wang J; Hao X
Breast Cancer Res Treat; 2010 Jul; 122(1):65-75. PubMed ID: 19728083
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
19. Reconstruction of temporal activity of microRNAs from gene expression data in breast cancer cell line.
Jayavelu ND; Bar N
BMC Genomics; 2015 Dec; 16():1077. PubMed ID: 26763900
[TBL] [Abstract][Full Text] [Related]
20. Integrative network analysis of transcriptomics data reveals potential prognostic biomarkers for colorectal cancer.
Mahajan M; Sarkar A; Mondal S
Cancer Med; 2024 Jun; 13(11):e7391. PubMed ID: 38872418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
